Dr Reddys Laboratories Stock Widgets and Gadgets
RDY Stock | USD 72.15 1.01 1.42% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- RDY Dr Reddys Laboratories
- Latest Zacks Industry Outlook Highlights Teva, Dr. Reddys and Viatris
- RDY 72.15 1.01
- Low 71.47
- High 72.23
- Alpha 0.0814
- Beta 0.0177
- Return On Equity 0.21
- Return On Asset 0.12
- Profit Margin 0.19 %
- Operating Margin 0.25 %
- Current Valuation (40.69 B)
- Shares Outstanding 166.53 M
- Shares Owned By Institutions 15.02 %
- Number Of Shares Shorted 625.76 K
- Price To Earning 31.58 X
- Price To Book 3.70 X
- Price To Sales 0.04 X
- Revenue 245.88 B
- Gross Profit 113.84 B
- EBITDA 108.78 B
- Net Income 60.48 B
- Cash And Equivalents 2.93 B
- Cash Per Share 208.58 X
- Total Debt 13.47 B
- Debt To Equity 0.12 %
- Current Ratio 1.98 X
- Book Value Per Share 1,609 X
- Cash Flow From Operations 58.87 B
- Short Ratio 3.51 X
- Earnings Per Share 3.75 X
- Price To Earnings To Growth 4.71 X
- Target Price 79.92
- Number Of Employees 25.86 K
- Beta 0.34
- Market Capitalization 12.01 B
- Total Asset 322.85 B
- Retained Earnings 215.59 B
- Working Capital 118.53 B
- Current Asset 1.81 B
- Current Liabilities 976 M
- Annual Yield 0.01 %
- Five Year Return 0.72 %
- Net Asset 322.85 B
- Last Dividend Paid 40.0
- Accumulation Distribution 0.0105
- Daily Balance Of Power 1.328947
- Rate Of Daily Change 1.01
- Day Median Price 71.85
- Day Typical Price 71.95
- Market Facilitation Index 0.76
- Price Action Indicator 0.81
- Period Momentum Indicator 1.01
Market Snapshot Widget Example
DAX Index Germany | 17,861 0.70 | |
Taiwan Weighted Taiwan | 19,411 0.59 | |
PSI 20 Stock Portugal | 6,515 3.50 | |
CROBEX Croatia | 2,803 0.14 | |
Budapest SE Hungary | 65,126 0.12 | |
IDX 30 Jakarta Indonesia | 467.48 0.14 | |
ISEQ 20 Price Ireland | 1,646 0.05 | |
NYSE Comp USA | 17,602 0.82 | |
Tel Aviv 35 Israel | 1,912 0.55 | |
Coreshares Index Tracker South Afric | 1,026 0.59 | |
IPC MEXICO Mexico | 56,552 1.23 | |
KL Technology Malaysia | 62.69 0.14 | |
IBEX 35 Index Spain | 10,890 1.50 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,554 0.49 | |
SPASX Dividend Opportunities Australia | 1,655 0.68 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,205 0.11 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,290 0.01 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,173 0.06 | |
Basic Materials Brazil | 5,966 0.05 | |
Swiss Leader Price Switzerland | 1,847 0.38 | |
Fondo Mutuo ETF Chile | 1,407 0.21 | |
Athens General Comp Greece | 1,420 1.99 | |
Stock Exchange Of Thailand | 1,350 1.31 | |
PX Prague Stock Czech Repub | 1,551 0.02 | |
THE PHILIPPINE STOCK Philippines | 6,444 0.02 | |
WIG 30 Poland | 3,102 1.72 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Dr Reddys in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Dr Reddys
Compare Dr Reddys To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for RDY Stock analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.103 | Dividend Share 40 | Earnings Share 3.75 | Revenue Per Share 272.4618 | Quarterly Revenue Growth 0.066 |
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.